<\/p>\n
Lipikard<\/strong> obsahuje ezetimibe<\/strong> (10 mg), cholesterol-absorption inhibitor<\/strong> that blocks the NPC1L1 transporter in the small intestine. It is the go-to add-on therapy when a statin alone doesn’t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17–22%. Added to a statin, it produces an additional ~20–25% LDL reduction, totaling a 55–60% fall — equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The IMPROVE-IT<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10 mg once daily, any time, with or without food. Generally very well-tolerated — mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n \ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n Ezedoc is an oral lipid-lowering medicine containing ezetimibe<\/strong> (10 mg), manufactured by WHO-GMP certified manufacturer. Supplied in packs of 30, 60, 90 or 180 tablets. Ezetimibe is the first and only drug of the cholesterol-absorption inhibitor<\/strong> class. Originator brand: Zetia \/ Ezetrol<\/strong> (Merck, 2002).<\/p>\n Ezetimibe is a mainstay of second-line lipid management — the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30–60%); it is most powerful as an add-on.<\/p>\n Ezetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) transporter<\/strong> on enterocytes in the proximal small intestine. NPC1L1 is responsible for absorbing dietary and biliary cholesterol from the gut lumen into the enterocyte.<\/p>\n With NPC1L1 blocked:<\/p>\n Because ezetimibe and statins act on complementary pathways<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other’s side-effect profile.<\/p>\n Outcome data: the IMPROVE-IT trial<\/strong> (2015) showed adding ezetimibe to simvastatin in post-ACS patients reduced the composite CV endpoint by 6.4% (NNT 50 over 7 years), confirming that the LDL-lowering translates into real event reduction.<\/p>\n Standardn\u00ed d\u00e1vka:<\/strong> 10 mg once daily at any time of day, with or without food.<\/p>\n Ezetimibe is one of the best-tolerated lipid-lowering drugs. Adverse events are close to placebo rates in trials.<\/p>\n Common (< 5%):<\/strong><\/p>\n M\u00e9n\u011b \u010dast\u00e9:<\/strong><\/p>\n Store Ezedoc below 25°C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% — much less than a statin (30–60%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n Doubling a statin dose typically adds ~6% LDL reduction (the statin “rule of 6”). Adding ezetimibe adds ~20–25% LDL reduction. Adding ezetimibe is 3–4× more effective<\/strong> than doubling the statin, and without the dose-related rise in muscle symptoms. This is why modern guidelines favour statin + ezetimibe combination over pushing statin to maximum dose.<\/p>\n Yes — the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent — pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n Rarely. Ezetimibe monotherapy shows placebo-level muscle side effects. When combined with a statin, it does not meaningfully increase statin-related muscle symptoms compared with the statin alone.<\/p>\n You can order Ezedoc (10 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n Ezedoc is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>. V\u00e1\u0161 popis transakce p\u0159i platb\u011b kartou zobrazuje regulovan\u00e9ho zpracovatele plateb (regulovan\u00e9ho zpracovatele plateb kartou), nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku.<\/p>\n <\/p>\n Dal\u0161\u00ed produkty v Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n \u2705 Lowers Cholesterol Levels Ezedoc contains Ezetimibe.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
What Is Ezedoc?<\/h2>\n
What Is Ezedoc Used For?<\/h2>\n
\n
How Does Ezedoc Work?<\/h2>\n
\n
D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n
\n
Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n
\n
\n
Interakce s l\u00e9\u010divy<\/h2>\n
\n
Who Should Not Take Ezedoc?<\/h2>\n
\n
Skladov\u00e1n\u00ed<\/h2>\n
\u010casto kladen\u00e9 dotazy<\/h2>\n
Can I take Ezedoc instead of a statin?<\/h3>\n
How does Ezedoc compare to doubling my statin dose?<\/h3>\n
Does Ezedoc reduce heart attacks and strokes?<\/h3>\n
When should I take Ezedoc?<\/h3>\n
Does Ezedoc cause muscle pain like statins?<\/h3>\n
Where can I buy Ezedoc online?<\/h3>\n
Souvisej\u00edc\u00ed l\u00e9ky na cholesterol<\/h2>\n
\n
Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
Souvisej\u00edc\u00ed alternativy<\/h3>\n
\n
\n\u2705 Sni\u017euje riziko srde\u010dn\u00edch onemocn\u011bn\u00ed
\n\u2705 Prevents Atherosclerosis
\n\u2705 Prescribed by Doctors
\n\u2705 Mo\u017enost peror\u00e1ln\u00ed medikace<\/p>\n